Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India’s World-Class Biological Drugs Testing Center Sits Largely Unused

This article was originally published in PharmAsia News

Executive Summary

India's government built a set of world-class laboratories to serve as the central source for testing biotech drugs, but although it has had labs completed and opened since 2000, it has tested few drugs. The National Institute of Biologicals was ordered built in the early nineties and declared by law to serve as the testing center at the beginning of a biologicals wave. Since then, 350 biological drugs have entered the market, but few were tested at the lab, even though the huge facility was completed last year. Intended to house 85 scientists and 115 technicians, the NIB today is staffed by only nine scientists and a dozen or so technicians. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts